Pain Therapeutics Inc.

(PTIE) Trade

By |

Profile

Pain Therapeutics Inc is a biopharmaceutical company that develops novel drugs. The Company has four drug candidates in clinical programs, including Remoxy, Oxytrex, PTI-202 and a novel radio-labeled monoclonal antibody to treat metastatic melanoma.

Contact Information

Website: www.paintrials.com
Main Phone: +1 512 501-2444
Address: 7801 N. Capital of Texas Highway
Address 2: Suite 260
State: TX
City / Town: Austin
Country: USA
Postal Code: 78731

Issuer Information

Exchange: NGS
CEO: Remi Barbier
Employees: 9
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 2.23 $ 0.06 (2.77%)
Last Price 2.23 Change $ 0.06 Change % 2.77 Tick N/A
Bid 2.12 Bid Size 1,000.00 Ask 2.50 Ask Size 100.00
Open 2.15 High 2.29 Low 2.03 Prev Close 2.17
Last Trade Volume 176,576 52 Wk Hi 12.80 52 Wk Low 2.04
Market Cap 15.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 6,895,509.00 EPS (TTM) -1.74 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Sanford R. Robertson 1,000
Sanford R. Robertson 1,000
Remi Barbier 1,000
Peter S. Roddy 1,000
Grant L. Schoenhard 1,000
Grant L. Schoenhard 1,000
Nadav Friedmann 1,000
Sanford R. Robertson 1,000
Peter S. Roddy 1,000
Nadav Friedmann 1,000
Last 10 Sell Shares
Nadav Friedmann 1,000
Nadav Friedmann 1,000
Remi Barbier 1,000
Remi Barbier 1,000
Remi Barbier 1,000
Remi Barbier 1,000
Remi Barbier 1,000
Remi Barbier 1,000
Remi Barbier 1,000
Remi Barbier 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 17.49 17.49 17.49 17.49
Low Target Price Estimate 17.49 17.49 17.49 17.49
Mean Target Price Estimate 17.49 17.49 17.49 17.49
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 09/13/16 09/13/16 09/13/16 09/13/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 5 5 5 5